Doherty Catherine T. 4
4 · QUEST DIAGNOSTICS INC · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics (DGX) EVP Catherine Doherty Receives RSUs, Sells Shares
What Happened Catherine T. Doherty, EVP, Regional Businesses at Quest Diagnostics, received equity awards and also disposed of shares in connection with those awards. On 2026-02-18 she was granted 2,928 shares and 13,514 restricted stock units (total 16,442 RSU-type awards). To cover tax withholding obligations tied to the vesting, 433 shares (at $210.01, $90,934) and 728 shares (at $206.99, $150,689) were surrendered to the issuer on 2026-02-18. Separately, 1,433 shares were sold in an open-market transaction on 2026-02-19 at $204.83 for proceeds of $293,521. Total proceeds from the reported disposals were $535,144. Net change from awards minus disposals = +13,848 shares (assuming RSUs convert to common stock).
Key Details
- Transaction dates and prices:
- 2026-02-18: Award of 2,928 shares and 13,514 RSUs (price $0.00 for award).
- 2026-02-18: 433 shares surrendered at $210.01 (tax withholding) — $90,934.
- 2026-02-18: 728 shares surrendered at $206.99 (tax withholding) — $150,689.
- 2026-02-19: Open-market sale of 1,433 shares at $204.83 — $293,521.
- Total disposed shares: 2,594; total disposal proceeds: $535,144.
- Shares owned after transaction: Not reported in the Form 4 filing.
- Notable footnotes:
- F1: Awards reported are restricted stock units (RSUs).
- F2: Dispositions to the issuer were to cover tax withholding from RSU vesting.
- F3: The open-market sale was effected pursuant to a Rule 10b5-1 sales plan.
- Filing timeliness: Report filed 2026-02-20 for transactions on 2026-02-18 and 02-19; filing appears timely (no late-filing flag reported).
Context
- This was primarily an award/vesting event (RSUs) with routine tax-withholding share surrender and a planned sale under a 10b5-1 plan. The surrender of shares to cover taxes is a common, administrative (non-bullish) action; the 10b5-1 sale is a prearranged plan and does not necessarily reflect contemporaneous market views.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-18+2,928→ 70,996 total - Tax Payment
Common Stock
[F2]2026-02-18$210.01/sh−433$90,934→ 70,563 total - Tax Payment
Common Stock
[F2]2026-02-18$206.99/sh−728$150,689→ 69,835 total - Sale
Common Stock
[F3]2026-02-19$204.83/sh−1,433$293,521→ 68,402 total - Award
Non-Qualifed Stock Option (right to buy)
[F5]2026-02-18+13,514→ 13,514 totalExercise: $204.96Exp: 2036-02-18→ Common Stock (13,514 underlying)
- 4,503(indirect: By 401(k))
Common Stock
[F4]
Footnotes (5)
- [F1]Represents an award of restricted stock units.
- [F2]Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
- [F3]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- [F4]These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- [F5]The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.